---
title: Gene editing with CRISPR technology
videoId: 0OXaanDHENI
---

From: [[⁨cleoabram⁩]] <br/> 

CRISPR-Cas9 is a microscopic technology that provides the power to edit genes while a person is alive <a class="yt-timestamp" data-t="00:00:00">[00:00:00]</a>. This technology can potentially cure diseases, prevent others, boost human physical abilities, and even give future generations abilities never before seen, effectively putting evolution into human hands <a class="yt-timestamp" data-t="00:00:07">[00:00:07]</a>. This is not a future concept; it is already being used in real medicines, to grow new crops, and to create new species <a class="yt-timestamp" data-t="00:00:21">[00:00:21]</a>. Jennifer Doudna won the Nobel Prize for discovering CRISPR-Cas9 <a class="yt-timestamp" data-t="00:00:34">[00:00:34]</a>. Deciding how to use this new power will be one of humanity's greatest challenges and one of the biggest opportunities to reduce human suffering <a class="yt-timestamp" data-t="00:00:41">[00:00:41]</a>.

## The CRISPR Breakthrough

For over a century, scientists have known that cells contain molecules carrying information in a four-part code, which cells use as a blueprint for making proteins that govern human traits, from appearance to disease susceptibility <a class="yt-timestamp" data-t="00:03:00">[00:03:00]</a>. However, for most of that century, this genetic code could only be read, not changed <a class="yt-timestamp" data-t="00:03:17">[00:03:17]</a>.

Early gene manipulation tools came from studying viruses, which naturally insert into human DNA <a class="yt-timestamp" data-t="00:03:44">[00:03:44]</a>. Insights from how viruses manipulate DNA led to the development of tools like Zinc-finger nucleases and TALEN proteins to alter DNA sequences <a class="yt-timestamp" data-t="00:04:03">[00:04:03]</a>. While these demonstrated the possibility and power of DNA manipulation, they were "bespoke," meaning a new one had to be created for every single change desired, making them expensive and time-consuming to produce and deploy <a class="yt-timestamp" data-t="00:04:42">[00:04:42]</a>.

CRISPR's breakthrough lies in its programmability <a class="yt-timestamp" data-t="00:05:00">[00:05:00]</a>. Viruses and bacteria naturally use proteins directed by RNA molecules, which are chemical cousins of DNA and interact with DNA sequences <a class="yt-timestamp" data-t="00:05:07">[00:05:07]</a>. Scientists learned that by understanding how RNA recoding works, they could easily manipulate and change the DNA sequences that CRISPR recognizes <a class="yt-timestamp" data-t="00:05:21">[00:05:21]</a>. This makes CRISPR a programmable tool that can be directed to almost any DNA sequence for targeted, easily controlled changes <a class="yt-timestamp" data-t="00:05:33">[00:05:33]</a>. Essentially, humanity has moved from observing genes to quick, precise editing, like a text editor for the instruction manual of life <a class="yt-timestamp" data-t="00:05:46">[00:05:46]</a>.

## [[applications_of_crispr_in_medicine_and_agriculture | Applications of CRISPR]]

The ability to manipulate DNA sequences with CRISPR has profound implications, from changing crop resistance to drought and increasing yields to altering heritable traits in human embryos for future generations <a class="yt-timestamp" data-t="00:06:11">[00:06:11]</a>.

### Human Health Applications

CRISPR offers the power to eliminate diseases like hemophilia, sickle cell anemia, Alzheimer's, and Huntington's disease <a class="yt-timestamp" data-t="00:01:09">[00:01:09]</a>.

There is a significant divide in the debate over [[ethical_implications_of_genetic_modifications | genetic modifications]] between editing somatic cells (non-reproductive cells, where changes end with the individual) versus germline cells (reproductive cells, where changes are passed down to future generations) <a class="yt-timestamp" data-t="00:07:13">[00:07:13]</a>. Altering DNA in embryos has profound implications because embryos cannot make that decision, and the change is permanent, inherited by all future generations <a class="yt-timestamp" data-t="00:08:00">[00:08:00]</a>.

The types of changes range from treating agreed-upon diseases, to preventing future diseases, to what some might call [[potential_genetic_enhancements_and_their_implications | enhancements]], moving individuals or their descendants into new possibilities for humans, or even "super enhancements" <a class="yt-timestamp" data-t="00:08:34">[00:08:34]</a>.

#### Curing Sickle Cell Disease

A major success of the CRISPR field is the approval of a CRISPR-based therapy for sickle cell disease patients by the US Food and Drug Administration and its UK counterpart in late 2023 <a class="yt-timestamp" data-t="00:09:35">[00:09:35]</a>. This disease results from a single genetic mutation <a class="yt-timestamp" data-t="00:09:56">[00:09:56]</a>. The CRISPR-based treatment is a "one and done" therapy that suppresses the effect of the disease-causing mutation by turning on the production of fetal hemoglobin, a protein normally only made in the womb <a class="yt-timestamp" data-t="00:10:24">[00:10:24]</a>. Patients like Victoria Gray, the first US patient to receive this therapy, have not had another sickle cell crisis since <a class="yt-timestamp" data-t="00:10:55">[00:10:55]</a>. This is considered a treatment for an individual, not currently used in the human germline <a class="yt-timestamp" data-t="00:11:31">[00:11:31]</a>.

#### Addressing Huntington's Disease

Huntington's disease is a neurodegenerative disorder caused by a single, well-defined gene <a class="yt-timestamp" data-t="00:17:07">[00:17:07]</a>. It often runs in families, with symptoms appearing in mid-life <a class="yt-timestamp" data-t="00:16:40">[00:16:40]</a>. CRISPR could potentially remove this disease-causing mutation from an embryo, ensuring the individual born does not bear the trait and does not pass it on to their children <a class="yt-timestamp" data-t="00:17:37">[00:17:37]</a>. While this capability would be profound and potentially unethical *not* to use for that purpose if safe, it is not yet ready due to complexities in controlling DNA repair in embryos <a class="yt-timestamp" data-t="00:18:02">[00:18:02]</a>.

#### Preventing Future Diseases

CRISPR is being explored for preventing diseases like Alzheimer's (related to APOE4), heart disease (PCSK9), or cancer (BA) <a class="yt-timestamp" data-t="00:26:11">[00:26:11]</a>. A clinical trial is already running for people susceptible to high cholesterol buildup, using CRISPR as a preventative measure to edit liver DNA and prevent cholesterol accumulation <a class="yt-timestamp" data-t="00:26:42">[00:26:42]</a>. If successful, this could be a one-time therapy replacing daily medication, offering freedom from worrying about early heart attacks <a class="yt-timestamp" data-t="00:27:09">[00:27:09]</a>.

#### Genetic Enhancements

The category of [[potential_genetic_enhancements_and_their_implications | genetic enhancements]] includes changes like eye color or height, but more interestingly, enhancements for health not directly related to disease <a class="yt-timestamp" data-t="00:29:09">[00:29:09]</a>. Examples include:
*   **MSTN gene**: Associated with building larger muscles <a class="yt-timestamp" data-t="00:29:27">[00:29:27]</a>.
*   **DEEC2 gene**: Associated with needing less sleep <a class="yt-timestamp" data-t="00:29:37">[00:29:37]</a>.
*   **Pain perception gene**: Natural variations exist in the human population where certain gene formats lead to natural pain tolerance <a class="yt-timestamp" data-t="00:29:53">[00:29:53]</a>. This could be used to reduce pain in cancer patients or those with chronic pain <a class="yt-timestamp" data-t="00:30:23">[00:30:23]</a>.

These [[potential_genetic_enhancements_and_their_implications | enhancements]] raise questions about where to draw the line between treatment and enhancement, as it's a continuum <a class="yt-timestamp" data-t="00:30:37">[00:30:37]</a>. Super enhancements, like creating super athletes with extreme height or muscle structure, are currently not realistic because the genetics are not well understood, and altering one gene can have unforeseen effects on others <a class="yt-timestamp" data-t="00:37:04">[00:37:04]</a>.

### Plant and Animal Applications

The global impact of CRISPR will likely first be seen in plant and animal manipulations <a class="yt-timestamp" data-t="00:38:24">[00:38:24]</a>. Unlike human applications, changes in plants and animals can be experimented with more readily and in greater numbers <a class="yt-timestamp" data-t="00:38:45">[00:38:45]</a>. CRISPR provides precise manipulation that traditional plant breeders could only dream of <a class="yt-timestamp" data-t="00:38:57">[00:38:57]</a>.

Traditionally, plant breeders introduced random changes using chemicals or radiation, taking decades and often resulting in undesirable coupled traits (e.g., thornless roses losing their smell) <a class="yt-timestamp" data-t="00:39:09">[00:39:09]</a>. CRISPR allows targeted, precise changes that alter only one trait without affecting others <a class="yt-timestamp" data-t="00:40:05">[00:40:05]</a>. Furthermore, CRISPR can be used to modify multiple genes (5, 10, 15 at a time) in plants simultaneously, enabling sophisticated alterations safely and precisely <a class="yt-timestamp" data-t="00:40:17">[00:40:17]</a>.

Examples:
*   A CRISPR-edited tomato has been approved in Japan for higher nutritional value <a class="yt-timestamp" data-t="00:41:06">[00:41:06]</a>.
*   Non-browning mushrooms created using CRISPR exist <a class="yt-timestamp" data-t="00:41:27">[00:41:27]</a>.
*   Tomatoes with much higher yields than unedited plants have been created without affecting taste or appearance <a class="yt-timestamp" data-t="00:41:34">[00:41:34]</a>.

In the United States, the USDA has ruled that plant DNA changes that could have been achieved through traditional breeding (even if sped up by CRISPR) are not considered genetically modified and are not regulated <a class="yt-timestamp" data-t="00:42:02">[00:42:02]</a>. This means such crops could soon appear in grocery stores <a class="yt-timestamp" data-t="00:42:32">[00:42:32]</a>.

### [[ethical_and_ecological_implications_of_using_genetically_modified_organisms_for_climate_intervention | Climate Change Applications]]

One significant application relates to climate change: reducing methane emissions from cattle <a class="yt-timestamp" data-t="00:42:45">[00:42:45]</a>. Cattle produce a lot of methane, a potent greenhouse gas, primarily from gut bacteria <a class="yt-timestamp" data-t="00:43:09">[00:43:09]</a>. Scientists are working to use CRISPR to alter the metabolism of these methane-producing bacteria in the cow's microbiome, dialing down methane production and turning up nutrient generation <a class="yt-timestamp" data-t="00:43:42">[00:43:42]</a>. The goal is an easy-to-deploy method, like a one-time pill for calves, that sustainably edits their microbiome for life <a class="yt-timestamp" data-t="00:44:51">[00:44:51]</a>. This targets the microorganisms, not the cow itself <a class="yt-timestamp" data-t="00:45:07">[00:45:07]</a>.

### Editing Microorganisms within Humans

CRISPR could also edit the human microbiome to impact health <a class="yt-timestamp" data-t="00:45:18">[00:45:18]</a>. Research suggests the human microbiome profoundly impacts health, and CRISPR could be used to turn down the production of molecules produced by the microbiome that are correlated with disease susceptibility, such as preventing asthma in children <a class="yt-timestamp" data-t="00:45:29">[00:45:29]</a>. There is also potential in understanding the connection between the microbiome and the brain, and the microbiome and the immune system, particularly in relation to inflammation and diseases like Alzheimer's <a class="yt-timestamp" data-t="00:46:31">[00:46:31]</a>.

## [[challenges_and_opportunities_in_crispr_development_and_implementation | Challenges and Ethical Considerations]]

### Delivery and Precision

A significant challenge for CRISPR therapies, especially for organs like lungs, liver, or brain, is effectively delivering CRISPR molecules into specific cells within the body <a class="yt-timestamp" data-t="00:13:01">[00:13:01]</a>. The ideal scenario is to target only the affected cells without disturbing others <a class="yt-timestamp" data-t="00:14:56">[00:14:56]</a>. This is tricky because different cell types are intermingled, and while cells have "zip code molecules" on their surface, identifying and specifically targeting them is ongoing research <a class="yt-timestamp" data-t="00:15:15">[00:15:15]</a>. Viruses are an inspiration for delivery mechanisms because they excel at recognizing and delivering molecules to specific cell types <a class="yt-timestamp" data-t="00:15:48">[00:15:48]</a>.

For the liver, delivery is somewhat easier because it naturally filters toxins and accumulates molecules <a class="yt-timestamp" data-t="00:28:06">[00:28:06]</a>. Lipid nanoparticles, similar to those used in COVID vaccines, are being used to deliver CRISPR to the liver in clinical trials <a class="yt-timestamp" data-t="00:28:46">[00:28:46]</a>. While progress is being made, safe and effective in-body delivery for wider application is still a challenge being actively worked on <a class="yt-timestamp" data-t="00:13:41">[00:13:41]</a>.

### Risks and Safety

With any therapy, especially germline editing, the risks must outweigh the benefits <a class="yt-timestamp" data-t="00:19:22">[00:19:22]</a>. Changes made to the germline are permanent and passed to future generations, so confidence in positive and desired outcomes is crucial <a class="yt-timestamp" data-t="00:19:34">[00:19:34]</a>.

The controversial 2018 case of a scientist editing human embryos to prevent HIV transmission highlighted key concerns <a class="yt-timestamp" data-t="00:18:45">[00:18:45]</a>:
*   The technology had never been tested in animals prior to human application <a class="yt-timestamp" data-t="00:20:29">[00:20:29]</a>.
*   Well-known and safer treatments already existed to prevent HIV transmission from parent to child <a class="yt-timestamp" data-t="00:20:43">[00:20:43]</a>.
*   The genome editing was not a "clean edit," resulting in "chimeras" (a mixture of different genetic makeups in the embryos' cells), with unknown long-term effects <a class="yt-timestamp" data-t="00:21:14">[00:21:14]</a>.

For preventative therapies, safety demands are even higher, as individuals not currently ill would not want to risk becoming ill from a treatment <a class="yt-timestamp" data-t="00:27:32">[00:27:32]</a>.

### Accessibility and the "Gene Gap"

A concern, particularly for enhancements, is the potential creation of a "gene gap" where access to the technology is based on wealth or other factors, leading to a divide in society, reminiscent of the movie *Gattaca* <a class="yt-timestamp" data-t="00:31:20">[00:31:20]</a>. However, historically, many expensive technologies become less expensive and more widely available over time <a class="yt-timestamp" data-t="00:31:44">[00:31:44]</a>. The argument against developing a technology because it's initially only available to a few is often problematic, as early development can lead to widespread future benefits <a class="yt-timestamp" data-t="00:32:33">[00:32:33]</a>.

### Preimplantation Genetic Diagnosis (PGD) and Embryo Selection

CRISPR use in human embryos would occur in the context of in vitro fertilization (IVF) <a class="yt-timestamp" data-t="00:33:55">[00:33:55]</a>. IVF technology allows for embryo selection using PGD (Preimplantation Genetic Diagnosis), where embryos can be screened to identify or avoid certain traits, such as disease-causing mutations <a class="yt-timestamp" data-t="00:34:11">[00:34:11]</a>.

The key difference is that PGD merely selects existing embryos, whereas CRISPR can actually make changes to genes that might be present in all embryos from a specific couple <a class="yt-timestamp" data-t="00:34:46">[00:34:46]</a>. IVF itself is a difficult, time-consuming, and expensive process <a class="yt-timestamp" data-t="00:35:05">[00:35:05]</a>. Future [[scientific_advancements_in_egg_and_embryo_preservation | advancements in gametes]] (eggs and sperm) could change the landscape of what's possible in human reproduction in the coming decades <a class="yt-timestamp" data-t="00:35:30">[00:35:30]</a>.

## Future Outlook

The development of CRISPR highlights that science is a human endeavor driven by curiosity <a class="yt-timestamp" data-t="00:48:36">[00:48:36]</a>. Fundamental breakthroughs often come from asking "I wonder how something works" and then investigating it <a class="yt-timestamp" data-t="00:48:49">[00:48:49]</a>. Continued support for curiosity-driven science is crucial for future generations <a class="yt-timestamp" data-t="00:49:48">[00:49:48]</a>.

Current curiosities include:
*   Investigating the evolution of bipedalism using CRISPR in rodents <a class="yt-timestamp" data-t="00:50:10">[00:50:10]</a>.
*   Further understanding the connection between microbiomes and human health by tweaking microbial genes and observing effects on human cells <a class="yt-timestamp" data-t="00:50:40">[00:50:40]</a>.
*   Developing more effective ways to deliver molecules specifically into cells, learning from natural processes in viruses and bacteria <a class="yt-timestamp" data-t="00:51:08">[00:51:08]</a>.

Few technologies are inherently good or bad; what matters is how they are used <a class="yt-timestamp" data-t="00:52:35">[00:52:35]</a>. The possibilities of CRISPR, both good and bad, are limited only by human imagination <a class="yt-timestamp" data-t="00:52:40">[00:52:40]</a>. The power to control the species' genetic future is both awesome and terrifying, and deciding how to handle it may be humanity's biggest challenge <a class="yt-timestamp" data-t="00:53:02">[00:53:02]</a>.